|
ZNF281 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.251400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.128000E-01 |
| Normal-vs-Stage2 |
4.770400E-01 |
| Normal-vs-Stage3 |
5.465200E-01 |
| Normal-vs-Stage4 |
4.452100E-02 |
| Stage1-vs-Stage2 |
5.725000E-01 |
| Stage1-vs-Stage3 |
6.426200E-01 |
| Stage1-vs-Stage4 |
4.849800E-02 |
| Stage2-vs-Stage3 |
9.183000E-01 |
| Stage2-vs-Stage4 |
3.301800E-01 |
| Stage3-vs-Stage4 |
2.652200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.337000E-01 |
| Normal-vs-AfricanAmerican |
1.738810E-03 |
| Normal-vs-Asian |
5.206000E-01 |
| Caucasian-vs-AfricanAmerican |
3.080300E-03 |
| Caucasian-vs-Asian |
4.728800E-01 |
| AfricanAmerican-vs-Asian |
2.409600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.554300E-02 |
| Normal-vs-Female |
7.212800E-01 |
| Male-vs-Female |
6.306000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.775000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.808200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.522000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.462270E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.068400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.185400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.877200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.853200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.902400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.564010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.106400E-01 |
| Normal-vs-Grade 2 |
6.267600E-01 |
| Normal-vs-Grade 3 |
2.582500E-02 |
| Normal-vs-Grade 4 |
2.828400E-01 |
| Grade 1-vs-Grade 2 |
7.052600E-01 |
| Grade 1-vs-Grade 3 |
1.127560E-01 |
| Grade 1-vs-Grade 4 |
3.164000E-01 |
| Grade 2-vs-Grade 3 |
7.860400E-03 |
| Grade 2-vs-Grade 4 |
1.623810E-01 |
| Grade 3-vs-Grade 4 |
7.683000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.246600E-01 |
| Normal-vs-ccB subtype |
9.092400E-01 |
| ccA subtype-vs-ccB subtype |
6.111600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.455000E-01 |
| Normal-vs-N1 |
9.931600E-01 |
| N0-vs-N1 |
9.218000E-01 |
|
|
